News

On April 2, 2018, NABP will launch a streamlined licensure transfer application. How Pharmacist applicants submit transfer applications to the Delaware Board will change. For important details about the new application, including deadlines, see Licensure Transfer Program (eLTP). For information on submitting an eLTP application to the Delaware Board, see License Transfer.

Objective and Function

The primary objective of the Delaware Board of Pharmacy is to promote, preserve, and protect the public health, safety, and welfare. To meet this objective, the Board

• maintains a registry of drug outlets that manufacture, produce, sell, and distribute drugs, medications, and other materials used to diagnose and prevent illness and disease and to treat injury
• monitors the outlets to ensure safe practices
• develops standards for professional competency
• promulgates rules and regulations
• adjudicates complaints against professionals and, when necessary, imposes disciplinary sanctions.

The Board issues licenses to pharmacists and pharmacy interns. It also licenses pharmacies (both in Delaware and elsewhere), pharmaceutical manufacturers and distributors, medical gas dispensers and retail businesses that sell non-controlled prescription drugs for veterinary use.

The Board’s statutory authority is in 24 Del. C., Chapter 25.

Meetings

The Board meets the third Wednesday of every month, with the exception of July and December. All meetings are open to the general public and are held in the Cannon Building, 861 Silver Lake Boulevard, in Dover.

To ensure that business (such as a license application) is on the agenda for the Board to consider at its next meeting, submit all documentation to the Board office no later than 4:30 PM ten full working days before the meeting date.